Vice President, Clinical Development
Remix Therapeutics· Watertown, MA
vp seen live 18h ago
Remix Therapeutics is a clinical-stage biopharmaceutical company pioneering a new class of small-molecule medicines that modulate RNA processing to address the underlying drivers of disease. Our lead clinical program, REM-422, targets the RNA splicing machinery and is currently
Apply on Remix Therapeutics's site
This link goes straight to the employer's greenhouse page. Posted 107 days ago.We last confirmed it was open 18h ago.